"Area-level socioeconomic disadvantage and racial disparities in cancer in metropolitan Detroit"

"Area-level socioeconomic disadvantage and racial disparities in cancer in metropolitan Detroit"

Interested in racial health disparities research, but not sure where to start? Join us for this symposium! Data Science in Health Disparities Research Symposium https://datascienceinhealthdisparitie... March 11th, 2022 @ U-M, Department of Computational Medicine & Bioinformatics, Forum Hall, Palmer Commons Bldg., Ann Arbor, MI Seminar by Kristen Purrington, PhD Assistant Professor, Population Science, Wayne State University "Area-level socioeconomic disadvantage and racial disparities in cancer in metropolitan Detroit" Sponsored by The University of Michigan Rackham Graduate School and Department of Computational Medicine and Bioinformatics (DCMB) through a Rackham Faculty Allies and Student Allies Diversity Grant About Dr. Kristen Purrington: Dr. Purrington's research focuses on the impact of tumor biology and microenvironment on racial disparities in clinical outcomes for African Americans with cancer. Specifically, her three main areas of active research: (1) Characterizing clinically relevant molecular and immune profiles of breast and colorectal tumors in AAs, (2) understanding heritable susceptibility to breast, prostate, and colorectal cancer among AAs, particularly characterizing variants of uncertain significance in known cancer susceptibility genes, and (3) understanding the role of variability in estrogen receptor protein expression in racial disparities in ER+/HER2- breast cancer survival and treatment with endocrine therapy. She is also interested in the combination of genetic factors and traditional epidemiologic risk factors, such as hormonal exposures and mammographic density, and how these may explain risk, biological changes in tumors, and ultimately survival. Much of her research utilizes data and biospecimens from the Detroit Research on Cancer Survivors (ROCS) cohort study, an NCI-funded prospective cohort study of African Americans recently diagnosed with breast, prostate, colorectal, and lung cancers.